These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7895077)
1. Polyclonals to beta-amyloid(1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum. Mak K; Yang F; Vinters HV; Frautschy SA; Cole GM Brain Res; 1994 Dec; 667(1):138-42. PubMed ID: 7895077 [TBL] [Abstract][Full Text] [Related]
2. Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome. Cataldo AM; Barnett JL; Mann DM; Nixon RA J Neuropathol Exp Neurol; 1996 Jun; 55(6):704-15. PubMed ID: 8642396 [TBL] [Abstract][Full Text] [Related]
3. Quantification of plaque types in sulci and gyri of the medial frontal lobe in patients with Alzheimer's disease. McKenzie JE; Gentleman SM; Royston MC; Edwards RJ; Roberts GW Neurosci Lett; 1992 Aug; 143(1-2):23-6. PubMed ID: 1436671 [TBL] [Abstract][Full Text] [Related]
4. Morphological study of amyloid fibrils and preamyloid deposits in the brain with Alzheimer's disease. Miyakawa T; Katsuragi S; Yamashita K; Ohuchi K Acta Neuropathol; 1992; 83(4):340-6. PubMed ID: 1575011 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody to the C-terminus of beta-amyloid. Yang F; Mak K; Vinters HV; Frautschy SA; Cole GM Neuroreport; 1994 Oct; 5(16):2117-20. PubMed ID: 7865758 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains. Schmidt ML; Lee VM; Forman M; Chiu TS; Trojanowski JQ Am J Pathol; 1997 Jul; 151(1):69-80. PubMed ID: 9212733 [TBL] [Abstract][Full Text] [Related]
7. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease. Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982 [TBL] [Abstract][Full Text] [Related]
8. beta-Amyloid protein is higher in Alzheimer's disease brains: description of a quantitative biochemical assay. Frucht SJ; Koo EH J Neuropathol Exp Neurol; 1993 Nov; 52(6):640-7. PubMed ID: 8229083 [TBL] [Abstract][Full Text] [Related]
9. Quantitative differences in beta/A4 protein subtypes in the parahippocampal gyrus and frontal cortex in Alzheimer's disease. Armstrong RA Dementia; 1994; 5(1):1-5. PubMed ID: 8156080 [TBL] [Abstract][Full Text] [Related]
10. Is the clustering of beta-amyloid (A beta) deposits in the frontal cortex of Alzheimer patients determined by blood vessels? Armstrong RA Neurosci Lett; 1995 Aug; 195(2):121-4. PubMed ID: 7478265 [TBL] [Abstract][Full Text] [Related]
11. Quantitative differences in the deposition of beta A4 protein in the sulci and gyri of frontal and temporal isocortex in Alzheimer's disease. Gentleman SM; Allsop D; Bruton CJ; Jagoe R; Polak JM; Roberts GW Neurosci Lett; 1992 Feb; 136(1):27-30. PubMed ID: 1635663 [TBL] [Abstract][Full Text] [Related]
12. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Barelli H; Lebeau A; Vizzavona J; Delaere P; Chevallier N; Drouot C; Marambaud P; Ancolio K; Buxbaum JD; Khorkova O; Heroux J; Sahasrabudhe S; Martinez J; Warter JM; Mohr M; Checler F Mol Med; 1997 Oct; 3(10):695-707. PubMed ID: 9392006 [TBL] [Abstract][Full Text] [Related]
13. The progression of beta-amyloid deposition in the frontal cortex of the aged canine. Satou T; Cummings BJ; Head E; Nielson KA; Hahn FF; Milgram NW; Velazquez P; Cribbs DH; Tenner AJ; Cotman CW Brain Res; 1997 Nov; 774(1-2):35-43. PubMed ID: 9452189 [TBL] [Abstract][Full Text] [Related]
15. Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease. Masliah E; Mallory M; Deerinck T; DeTeresa R; Lamont S; Miller A; Terry RD; Carragher B; Ellisman M J Neuropathol Exp Neurol; 1993 Nov; 52(6):619-32. PubMed ID: 8229081 [TBL] [Abstract][Full Text] [Related]
16. The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age. Fonseca MI; Head E; Velazquez P; Cotman CW; Tenner AJ Exp Neurol; 1999 Jun; 157(2):277-88. PubMed ID: 10364440 [TBL] [Abstract][Full Text] [Related]
17. Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET. Roberts BR; Lind M; Wagen AZ; Rembach A; Frugier T; Li QX; Ryan TM; McLean CA; Doecke JD; Rowe CC; Villemagne VL; Masters CL Brain; 2017 May; 140(5):1486-1498. PubMed ID: 28383676 [TBL] [Abstract][Full Text] [Related]
18. Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Lee SP; Falangola MF; Nixon RA; Duff K; Helpern JA Magn Reson Med; 2004 Sep; 52(3):538-44. PubMed ID: 15334572 [TBL] [Abstract][Full Text] [Related]
19. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Maggio JE; Stimson ER; Ghilardi JR; Allen CJ; Dahl CE; Whitcomb DC; Vigna SR; Vinters HV; Labenski ME; Mantyh PW Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5462-6. PubMed ID: 1608956 [TBL] [Abstract][Full Text] [Related]
20. Quantifying the pattern of beta/A4 amyloid protein distribution in Alzheimer's disease by image analysis. Bruce CV; Clinton J; Gentleman SM; Roberts GW; Royston MC Neuropathol Appl Neurobiol; 1992 Apr; 18(2):125-36. PubMed ID: 1620274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]